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Summary
Oncostatin M (OSM) is a 28-kD glycoprotein recently identified as a growth factor for human
multiple myeloma cells. It belongs to a family of distantly related cytokines that includes inter-
leukin 6, ciliary neurotrophic factor, leukemia-inhibitory factor, and interleukin 11 . These cy-
tokines initiate signaling by inducing either homodimerization of gpl30 or heterodimerization
of gp130 with leukemia-inhibitory factor receptor (3 components. Such dimerization in turn
activates receptor-associated tyrosine kinases. In the present study using U266B1 human multi-
ple myeloma cells, we show that OSM induces tyrosine phosphorylation and activation of
JAK2, but not JAK1 or Tyk2, kinases. The results also demonstrate that OSM induces direct
interaction ofJAK2 kinase with Grb2, an SH2/SH3 domain containing adaptor protein. The
SH2 domain of Grb2 is directly associated with tyrosine-phosphorylated JAK2. Furthermore,
the presence of Sos in the JAK2-Grb2 complex suggests a role for Ras in OSM-transduced
signaling.
O
ncostatin M (OSM),' a mediator of pleiotropic bio-
logical activities, binds with high affinity to the leu-
kemia-inhibitory factor (LIF)/OSM receptor (1). This
cytokine, along with other members of a cytokine super-
family, including IL-6, ciliary neurotrophic factor (CNTF),
LIF, and IL-11, has a gpl30 receptor component involved
in signal transduction across the cell membrane (2-4).
These cytokines first bind with high affinity to their spe-
cific receptor ot chain. The individual cytokine receptor
complexes then each associate with the same (3 signal-
transducing transmembrane glycoprotein, gpl30. gp130 is
recruited either as a homodimer or in association with the
LIF receptor for signal transduction pathways induced by
IL-6, LIF, and CNTF (5-7) . In the case of OSM, the mo-
lecular structure of its specific receptor has not yet been de-
scribed; however, OSM has been shownto bind directly to
gpl30 (8, 9) .
Two membrane-proximal regions in gpl30 have been
proposed to be important for signal transduction (10). These
domains are critical for receptor association with members
of the Janus family of protein tyrosine kinases (PTKs), such
as JAK1 and JAK2 (11-13). Previous studies have demon-
strated the involvement of tyrosine and serine/threonine
'Abbreviations used in this paper: CNTF, ciliary neurotrophic factor; DTT,
dithiothreitol; LIF, leukemia inhibitory factor; OSM, oncostatin M; PTK,
protein tyrosine kinase.
kinases in OSM-mediated intracellular signaling pathways
leading to activation of immediate early response genes
(14) . For example, studies in TF-1 cells have shown that
OSM induces tyrosine phosphorylation ofJAK2 and that
this kinase physically associates with gpl30 (15) . Moreover,
OSM and IL-6 have been shown to stimulate tyrosine
phosphorylation and mitogen-activated protein (MAP) ki-
nase (16, 17) . MAP kinase activation by receptor-associated
PTKs proceeds by way of a cascade that is dependent on
Grb2, the guanine nucleotide exchange protein son ofsev-
enless (Sos) and Ras (18, 19) . Grb2 is a key molecule in this
association through the ability of its SH2 domain to bind to
receptor or receptor-associated, tyrosine-phosphorylated
proteins. Sos binds to the SH3 domain of Grb2 and is in-
volved in exchange of GDP and GTP in the activation of
Ras (20, 21) .
The present study demonstrates that treatment with OSM
causes tyrosine phosphorylation ofJAK2, which then binds
directly to the SH2 domain ofGrb2. The results further in-
dicate that OSM-induced signaling in U266B1 cells in-
volves formation of a JAK2-Grb2-Sos complex.
Materials and Methods
Cell Culture.
￿
U226B1 cells were obtained from the American
Type Culture Collection (Rockville, MD). Cells were cultured
in RPMI 1640 medium supplemented with 10% fetal bovine se-
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(Gibco Laboratories, Grand Island, NY) . Cells were treated with
100 ng/ml ofrOSM (Bristol Meyers Squibb Pharmaceuticals Re-
search Institute, Seattle, WA) .
Reagents and Antibodies. Anti-Grb2 and anti-Sos antibodies
were purchased from Santa Cruz Biotechnology (San Diego,
CA); antiJAK2, antiJAK1, and anti-Tyk2 polyclonal antibodies
were obtained from Upstate Biotechnology, Inc. (Lake Placid,
NY) . The glutathioinine S-transferree (GST)Grb2 (full-length),
GST-Grb2 SH2, GST-Grb2 N-SH3, and GST-Grb2 C-SH3
fusion proteins were purchased from Santa Cruz Biotechnology.
Antiphosphotyrosine (anti-P-Tyr, 4G10) antibody was provided by
Dr. Thomas Roberts (Dana-Farber Cancer Institute, Boston, MA) .
Immunoprecipitation and Immunoblotting.
￿
Cell lysates were pre-
pared by resuspending U266B1 cells for 30 min on ice in lysis
buffer containing 50 mM Tris, pH 7.6, 150 mM NaCl, 1 mM
PMSF, 1 mM sodium vanadate, 1 mM dithiothreitol (DTT), 10
mM sodium fluoride, 1% Brij-96, and 10 Rg/ml each ofleupep-
tin and aprotinin. Equal amounts of proteins (250-300 Ftg) were
subjected to immunoprecipitation with the indicated antibodies,
and immune complexes were precipitated with protein A-Sepha-
rose (Pharmacia Biotechnology, Inc., Piscataway, NJ) . The re-
sulting precipitates were washed four times with lysis buffer and
resolved by SDS-PAGE under reducing conditions. Proteins
were then transferred to nitrocellulose filters, blocked by incuba-
tion in 5% dry milk in PBST (0.05% Tween-20 in PBS), and
probed with the indicated antibodies. Blots were then developed
by enhanced chemiluminesence (ECL; Amersham Corp., Arling-
ton Heights, IL) . Nitrocellulose blots were stripped by incubation
in 62.5 mM Tris-HCL, pH 6.8, containing 100 mM [3-ME and
2% SDS, for 30 min at 50°C. The blots were further washed
twice in PBST, reblocked with 5% dry milk in PBST, and re-
probed with another antibody.
Fusion Protein Binding Assays, Peptide Competition Assays, and
Far Western Analysis. The fusion proteins GST, GST-Grb2
(full-length), GST-Grb2 SH2, GST-Grb2 N-SH3, or GST-Grb2
C-SH3 were purified by affinity chromatography using glu-
tathione-Sepharose beads and equilibrated in lysis buffer. Cell ly-
sates were incubated with 2 1-tg ofimmobilized GST, GST-Grb2,
GST-Grb2 SH2, GST-Grb2 N-SH3, or GST-Grb2 C-SH3 fu-
sion proteins for 2 h at 4°C. The resulting protein complexes
were washed three times with lysis buffer containing 0.1% deter-
gent and boiled for 5 min in SDS buffer. The complexes were
then separated by 7 .5% SDS-PAGE and subjected to silver stain-
ing or immunoblot analysis with antiJAK2 kinase antibody.
Peptides were synthesized using Fmoc-Tyr (P03Me2)-OH for
incorporation of phosphotyrosine and were subsequently purified
by ether precipitation and preparative reverse-phase HPLC.
Amino acid analysis was used to confirm the sequence ofJAK2-
derived phosphopeptide. The fusion proteins were first incubated
with or without 50 PM tyrosine-phosphorylated peptide [IT-
PVrYHNMFALM], followed by incubation with the lysates from
OSM-treated U266B1 cells; adsorbates were analyzed by immu-
noblotting with antiJAK2.
For Far Western analysis, the lysates from OSM-treated cells
were subjected to immunoprecipitation with antiJAK2 or pre-
immune rabbit serum. The proteins were resolved by 7.5% SDS-
PAGE and transferred to nitrocellulose membrane. The filters
were first incubated with purified GST-Grb2 fusion protein or
with purified GST alone (negative control) at room temperature
for 2 h and then analyzed by immunoblotting with anti-Grb2.
JAK2 Autophosphorylation, Reprecipitation, and Binding Assays.
Cell lysates were immunoprecipitated with anitJAK2 antibody.
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After washing three times with lysis buffer containing 0.1% Brij-
96 and once with kinase buffer (20 mM Hepes, pH 7.6, 10 mM
MgCl2, 10 mM MnCl2, 1 mM DTT), in vitro kinase assays were
performed by adding 10 p.Ci [y-32P]ATP for 15 min at 30°C.
The proteins were analyzed by 7.5% SDS-PAGE and autoradiog-
raphy. JAK2 protein was excised from the gel and eluted at 37°C
in elution buffer (50 mM NH4HCO3, 1% SDS, and l mM
DTT). The eluate was diluted 10-fold with lysis buffer and sub-
jected to reprecipitation with antiJAK2, GST, GST-Grb2 (full
length), or GST-Grb2 SH2. The precipitates were analyzed by
7.5% SDS-PAGE and autoradiography.
Results and Discussion
Previous studies have demonstrated that OSM induces
proliferation of human plasmacytoma (22) and myeloma
cells (23) . Other studies in 3T3-L1 preadipocytes have
demonstrated that OSM can induce tyrosine phosphoryla-
tion of several proteins (15-17, 24) . JAK-family tyrosine
kinases have been shown to be involved in the signaling
pathways triggered by various cytokines, including erythro-
poietin, IL-3, growth hormone, prolactin, and interferons
(25-29). Moreover, other members of the OSM cytokine
family, such as IL-6, have been shown to activate JAK ki-
nases differentially in various cell types (30-32) . In the
present study, we stimulated U266B1 cells with OSM and
analyzed total cell lysates for proteins phosphorylated at ty-
rosine residues. OSM induced several tyrosine-phosphory-
lated proteins with molecular weights ranging from 40 to
150 kD (Fig. 1 A and data not shown) . The molecular mass
of one such protein is ^120-130 kD and is thus similar to
that ofJAK-fanuly tyrosine kinases, including JAK1, JAK2,
and Tyk2 (Fig. 1 A) (25). To determine whether the 120-
130 kD protein is a member of the JAK family, we assayed
for reactivity of that protein with antiJAK1, antiJAK2,
and anti-Tyk2 antibodies. In contrast with JAK1 and Tyk2,
immunoblot analysis with antiJAK2 demonstrated reactiv-
ity with 130-kD protein (Fig. 1 A and data not shown).
Taken together, these findings suggest that tyrosine phos-
phorylation ofJAK2 is constitutively low in U266B1 cells
and that treatment with OSM increases it three- to four-
fold.
To examine whether OSM induces activation ofJAK2
kinase in these cells, we treated U266B1 cells with OSM
for various time intervals, and performed in vitro immune
complex kinase assays on the antiJAK2 immunoprecipi-
tates. Activation ofJAK2 was detectable 2 min after OSM
stimulation and returned to near baseline levels at 30 min
(Fig. 1 B). OSM at 30 ng/ml was sufficient to induce acti-
vation ofJAK2 kinase (Fig. 1 Q .
Although OSM has been shown to be cross-linked to a
150-160-kD membrane protein (33), the specific composi-
tion and the basis for activation of the OSM receptor are
presently unclear. Studies of TF-1 cells have shown that
OSM induces tyrosine phosphorylation ofJAK2 and that
this kinase physically associates with gp130 (4, 15). Fur-
thermore, recent studies have demonstrated that OSM or
its related cytokines initiate signaling cascades involving di-Figure 1 . OSM induces tyrosine phosphorylation and activation of
JAK2 kinase . (A) U266B1 cells were stimulated with 100ng/ml OSM for
10 min at 37 °C and then lysed in 1`%o Brig-96 lysis buffer . Equal amounts
of proteins were resolved by 7.5% SDS-PAGE, transferred to nitrocellu-
lose, and subjected to immunoblotting with anti-P-Tyr or antiJAK2 .
Reactivity was determined by ECL . (B and C) U266B1 cells were treated
with either 100 ng/ml OSM for the indicated times (B) or at the indi-
cated concentrations ofOSM for 10 min (C) . Total cell lysates were pre-
pared and subjected to immunoprecipitation with antiJAK2 . In vitro im-
mune complex kinase assays were performed by providing [y32PJATP .
The proteins were resolved by 7 .5% SDS-PAGE, transferred to nitrocel-
lulose filters, and exposed . Filters were stripped and reinununoblotted
with antiJAK2 (C, bottom) .
verse proteins, such as phospholipase C--y, phosphatidyl-
inositol 3-kinase (PI-3K), Shc, Grb2, Raf-1, and ERK-1/2
(34) . Because these studies suggested the involvement of
JAK2 in OSM-induced signaling, antiJAK2 immunopre-
cipitates were analyzed for potential binding proteins in
U266B1 cells . The finding by Coomassie blue staining that
a 26-kD protein coprecipitates withJAK2 kinase raised the
possibility of an interaction with the SH2/SH3 domain-
containing adaptor protein Grb2 . Indeed, immunoblot
analysis of antiJAK2 immunoprecipitates with anti-Grb2
revealed increased reactivity with a 26-kD protein after
OSM treatment (Fig. 2 A) . To provide additional support
for an association between Grb2 and JAK2 kinase, anti-
Grb2 immunoprecipitates were analyzed for reactivity with
antiJAK2 . The results demonstrate that Grb2 associates
with JAK2 and that this association is increased by OSM
treatment (Fig . 2 B) . In these experiments, reprobing the
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Figure 2 . JAK2 associates with Grb2 . (A) U266B1 cells were stimu-
lated with 100 ng/ml OSM for 10 min . Total cell lysates were immuno-
precipitated with antiJAK2, and the immune complexes were then sub-
jected to immunoblotting with anti-Grb2 . Reprobing of the blots with
antiJAK2 demonstrated equal amounts ofprotein. (B) Anti-Grb2 immu-
noprecipitates were immunoblotted with antiJAK2, and blots were sub-
sequently reprobed with anti-Grb2 to show equal amounts ofprotein . (C)
Lysate from OSM-treated cells was incubated with GST immobilized on
glutathione-Sepharose, and lysates from control or OSM-treated U266B1
cells were incubated with immobilized GST-Grb2 (full-length) fusion
protein . The adsorbed proteins were separated by 7.5% SDS-PAGE and
subjected to immunoblotting with antiJAK2 . (D) Lysates from control
and OSM-treated U266B1 cells were incubated with GST-Grb2 SH2 .
The adsorbates were analyzed by immunoblotting with anti-JAK2 . (E)
GST-Grb2 SH-2 fusion protein was incubated (1 h, 4°C) in the presence
(+) or absence (-) of50 [LM oftyrosine-phosphorylated synthetic pep-
tide [ITPVpYHNMFALM) followed by incubation with lysates from
OSM-treated U266 cells ; adsorbates were analyzed by immunoblotting
with antiJAK2 .
blots with either antiJAK2 or anti-Grb2, respectively, dem-
onstrated equal amounts of proteins in each lane (Fig . 2A
and B, lower panel) . The interaction between Grb2 and
JAK2 kinase was further examined by incubating lysates
from control and OSM-treated U266B1 cells with a GST-
Grb2 (full-length) fusion protein. Analysis ofthe adsorbates
by immunoblotting with antiJAK2 revealed increased re-
activity with a 130-kD protein in the OSM-treated cells
(Fig . 2G .
To define the domains of Grb2 involved in the associa-
tion with JAK2, lysates from control and OSM-treated
U266B1 cells were incubated with GST fusion proteins
prepared from the SH3 (COOH- andNHZ-terminal) and
SH2 domains of Grb2 . Adsorbates obtained with the GST-
Grb2 C-SH3 and GST-Grb2 N-SH3 fusion proteins ex-
hibited little, if any, reactivity with antiJAK2 (data notshown) . In contrast, adsorbates from GST-Grb2 SH2 re-
vealed increased binding ofJAK2 in the OSM-stimulated
cells (Fig . 2 D) . Reprobing the same blot with anti-P-Tyr
revealed increases in tyrosine phosphorylation of JAK2
(data not shown) . To define further the site in JAK2 re-
sponsible for association with Grb2, we identified one po-
tential sequence [ITPVpYHNMFALM] in theNH2-termi-
nal domain of JAK2 and used tyrosine-phosphorylated
synthetic peptide in competition assays . Preincubation of
GST-Grb2 SH2 fusion protein with this peptide inhibited
binding of JAK2 by lysates of OSM-treated U266 cells
(Fig. 2 E), whereas no detectable inhibition ofJAK2 bind-
ing was observed in control lysates without competitor
peptide (Fig. 2 E) . These findings confirmed that the OSM-
induced association between JAK2 and Grb2 is mediated
primarily through the SH2 domain of Grb2 and that this
association is tyrosine phosphorylation dependent .
To determine whether the interaction between Grb2
andJAK2 is direct, we subjectedJAK2 immunoprecipitates
from OSM-treated U266B1 cells to autophosphorylation .
The 32p-labeledJAK2 (Fig . 3 A, lane 1) was excised (Fig . 3
A, lane 2) and eluted from SDS-PAGE gels and then incu-
bated with GST, GST-Grb2 SH2, or GST-Grb2 (full
length) (Fig . 3 A, lanes 3-5) . One portion of the labeled
JAK2 protein was also subjected to immunoprecipitation,
with antiJAK2 as a positive control (lane 6) . Analysis of
the second precipitates demonstrated direct binding of the
SH2 domain of Grb2 toJAK2 (Fig. 3 A) . To examine fur-
ther the direct Grb2JAK2 interaction, antiJAK2 immu-
noprecipitates from OSM-treated cell lysates were resolved
on SDS-PAGE and transferred to nitrocellulose . Filters
were then incubated either with purified GST-Grb2 fusion
protein or with GST (as a negative control) and the blots
analyzed by immunoblotting with anti-Grb2 . The appear-
ance ofp130-kD protein in the filter incubated with GST-
Grb2 confirmed direct association betweenJAK2 and Grb2
proteins (Fig. 3 B) .
Grb2 adaptor protein has been shown to link receptors
or receptor-associated PTKs to the guanine nucleotide ex-
change protein Sos and thus to the Ras activation pathway
(35-37) . To study the potential of JAK2 kinase in the
Grb2-Sos complex, we analyzed antiJAK2 immunopre-
cipitates by immunoblotting with anti-Sos . While little
binding of Sos was observed in the antiJAK2 immunopre-
cipitates in control cells, this association was increased in
OSM-stimulated lysates (Fig. 3 C, left) . In the converse ex-
periment, anti-Sos immunoprecipitates were assayed for re-
activity with JAK2 . The results demonstrate an increased
reactivity with JAK2 in OSM-stimulated U266131 cells
(Fig . 3 C, right) . Taken together, these findings indicate
that theJAK2-Sos interaction is mediated through Grb2 .
It is not clear how binding of Grb2 to JAK potentiates
the ability of Grb2 to activate Sos . The interaction of Grb2
with JAK2 may serve to translocate Sos adjacent to Ras,
which is located in the plasma membrane . Another possi-
bility is that the binding of Grb2 orJAK2 promotes the ty-
rosine phosphorylation of Sos by JAK2, thus stimulating
guanine nucleotide-releasing activity . The studies reported
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Figure 3 .
￿
Demonstration ofdirect association ofJAK2 with Grb2 SH2
domain. (A) OSM-treated cell lysates were immunoprecipitated with
antiJAK2 antibodies (l') . After in vitro autophosphorylation, the protein
was separated by 7.5% SDS-PAGE and analyzed by autoradiography
(lane 1) . TheJAK2 protein was excised from the gel (lane 2) and eluted at
4 °C in elution buffer . The eluate was diluted 10-fold with lysis buffer and
subjected to reprecipitation (2 ° ) with indicated GST fusion proteins
(lanes 3-5) and antiJAK2 (lane 6) . The proteins were resolved by 7.5%,
SDS-PAGE and analyzed by autoradiography. (B) The lysates from
OSM-treated cells were subjected to inununoprecipitation with anti-
JAK2 and preimmune rabbit serum. The proteins were separated by 7.5%
SDS-PAGE and transferred to nitrocellulose membrane . The filters were
first incubated with purified GST-Grb2 fusion protein or with purified
GST fusion protein alone (negative control) and then immunoblotted
with anti-Grb2 . (C) Control and OSM-treated cell lysates were subjected
to innnunoprecipitation with antiJAK2 or preimmune rabbit serum
(negative control) . The immunoprecipitates were analyzed by irnmuno-
blotting with anti-Sos (left) . Anti-Sos immunoprecipitates were also ana-
lyzed by immunoblotting with antiJAK2 (right) .
here demonstrate that, as shown for other cytokines, OSM
stimulation ofgrowth pathways leading to Ras activation is
mediated by Grb2 . However, in contrast to growth factor
receptors that interact directly with the Grb2-Sos complex,
stimulation by OSM leads to phosphorylation ofJAK2 ki-
nase . The interaction of Grb2-Sos complex with JAK2 in
OSM-stimulated myeloma cells may provide an additional
level of control, conferred by the OSM receptor, of this
pivotal signaling pathway . In summary, our results demon-
strate that OSM treatment of U266131 human myeloma
cells induces tyrosine phosphorylation and activation of
JAK2 kinase and potentiates its association with the SH2
domain of Grb2 . Since Sos was also detected in the com-
plexes ofJAK2-Grb2, we conclude that the JAK2-Grb2-
Sos complexes are involved in OSM-induced growth of
U266B1 cells .References
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